Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden · Delayed Price · Currency is SEK 49.05
+0.75 (1.55%)
Apr 14, 2026, 2:37 PM CET
STO:IBT.B Market Cap
STO:IBT.B has a market cap or net worth of 680.31 million as of April 14, 2026. Its market cap has increased by 53.96% in one year.
Market Cap
680.31M
Enterprise Value
536.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
49.05
Market Cap Chart
Since March 29, 2016, STO:IBT.B's market cap has increased from 187.49M to 680.31M, an increase of 262.85%. That is a compound annual growth rate of 13.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 650.67M | -4.36% |
| Dec 30, 2025 | 680.31M | -5.78% |
| Dec 30, 2024 | 722.07M | -40.44% |
| Dec 29, 2023 | 1.21B | 116.00% |
| Dec 30, 2022 | 561.31M | -25.15% |
| Dec 30, 2021 | 749.91M | -40.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.39B |
| Genovis AB (publ.) | 1.31B |
| Xspray Pharma AB | 1.26B |
| SynAct Pharma AB | 1.00B |
| Cantargia AB | 974.56M |
| FluoGuide | 632.72M |
| Oncopeptides AB | 534.43M |
| Corline Biomedical AB | 411.10M |